Loncastuximab Tesirine

BPS Bioscience

Loncastuximab Tesirine

23

Research Use Only

Monoclonal

≥90%

Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma1,2.

-80°C

12352203